EyePoint, Inc. (EYPT) — Institutional Holders, Q2 2026

188 institutional investment managers reported a EYPT position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $1.3B. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 1 to 100. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

EYPT in Q2 2026: what funds did

Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.

New positions

24

Added to

64

Trimmed

60

Sold out

23

Biggest buyers

  1. Commodore CapitalAdded · +1,775,000 sh+$25.4M
  2. ADAGE CAPITAL PARTNERS GP, L.L.C.Added · +1,527,792 sh+$21.8M
  3. TWO SIGMA INVESTMENTSAdded · +750,828 sh+$10.7M
  4. DIMENSIONAL FUND ADVISORSAdded · +440,625 sh+$6.3M
  5. AMERIPRISE FINANCIALAdded · +425,148 sh+$6.1M

Biggest sellers

  1. Cormorant Asset ManagementTrimmed · -1,265,000 sh-$18.1M
  2. MORGAN STANLEYTrimmed · -759,379 sh-$10.9M
  3. StemPoint CapitalTrimmed · -472,293 sh-$6.8M
  4. ExodusPoint Capital ManagementSold out · -458,102 sh-$6.6M
  5. BANK OF AMERICATrimmed · -318,395 sh-$4.6M

EYPT 13F holders ranked 1–100 of 188

Institutional investors reporting a position in EyePoint, Inc. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
SUVRETTA CAPITAL MANAGEMENT#1 · 8,296,375 sh$118.6M0.0%
BlackRock#2 · 7,463,197 sh$106.7M+4.0%
Cormorant Asset Management#3 · 7,000,000 sh$100.1M-15.3%
FEDERATED HERMES#4 · 5,681,052 sh$81.2M+0.2%
ADAGE CAPITAL PARTNERS GP, L.L.C.#5 · 4,827,792 sh$69.0M+46.3%
FRANKLIN RESOURCES#6 · 4,807,078 sh$68.7M-4.8%
Commodore Capital#7 · 4,600,000 sh$65.8M+62.8%
Jupiter Topco#8 · 3,770,381 sh$53.9M—
VANGUARD CAPITAL MANAGEMENT#9 · 3,630,252 sh$51.9M+2.0%
Paradigm Biocapital Advisors#10 · 2,890,397 sh$41.3M-8.0%
STATE STREET#11 · 2,357,545 sh$33.7M+12.4%
GEODE CAPITAL MANAGEMENT#12 · 2,062,390 sh$29.5M+4.0%
abrdn plc#13 · 2,008,802 sh$28.7M+15.6%
CITADEL ADVISORS#14 · 1,977,610 sh$28.3M+3.8%
BALYASNY ASSET MANAGEMENT L.P.#15 · 1,812,358 sh$25.9M+26.0%
Parkman Healthcare Partners#16 · 1,288,163 sh$18.4M-4.9%
EVENTIDE ASSET MANAGEMENT#17 · 1,245,583 sh$17.8M0.0%
TWO SIGMA INVESTMENTS#18 · 1,181,143 sh$16.9M+174.5%
Essex Woodlands Management#19 · 1,084,857 sh$15.5M0.0%
ORBIMED ADVISORS#20 · 1,069,147 sh$15.3M0.0%
5AM Venture Management#21 · 1,050,000 sh$15.0M0.0%
Rosalind Advisors#22 · 988,230 sh$14.1M-4.7%
VANGUARD PORTFOLIO MANAGEMENT#23 · 971,014 sh$13.9M+22.3%
AMERIPRISE FINANCIAL#24 · 848,410 sh$12.1M+100.4%
DIMENSIONAL FUND ADVISORS#25 · 841,746 sh$12.0M+109.8%
HSBC PLC#26 · 833,455 sh$11.9M0.0%
Candriam S.C.A.#27 · 787,769 sh$11.3M+16.8%
Artia Global Partners#28 · 767,098 sh$11.0M0.0%
Blue Owl Capital#29 · 762,594 sh$10.9M-16.4%
NORTHERN#30 · 720,917 sh$10.3M+6.5%
Patient Square Capital#31 · 720,000 sh$10.3M-9.4%
Principia Wealth Advisory#32 · 649,944 sh$9.3M+2.6%
CHARLES SCHWAB INVESTMENT MANAGEMENT#33 · 647,613 sh$9.3M+1.2%
Sio Capital Management#34 · 623,130 sh$8.9M-13.7%
VANGUARD FIDUCIARY#35 · 559,216 sh$8.0M+10.9%
Alyeska Investment Group, L.P.#36 · 509,403 sh$7.3M0.0%
MILLENNIUM MANAGEMENT#37 · 500,093 sh$7.2M+5.2%
GOLDMAN SACHS GROUP#38 · 465,087 sh$6.7M-33.5%
Simplify Asset Management#39 · 400,044 sh$5.7M+22.7%
Ghisallo Capital Management#40 · 350,000 sh$5.0MNew
StemPoint Capital#41 · 338,471 sh$4.8M-58.3%
MORGAN STANLEY#42 · 336,730 sh$4.8M-69.3%
E Fund Management , Ltd.#43 · 330,774 sh$4.7M+250.0%
Jump Financial#44 · 320,757 sh$4.6M+61.7%
Bleichroeder#45 · 316,515 sh$4.5M0.0%
Woodline Partners#46 · 300,463 sh$4.3M+199.1%
Eversept Partners#47 · 297,735 sh$4.3MNew
Rock Springs Capital Management#48 · 268,519 sh$3.8M+3.8%
CITIGROUP#49 · 266,910 sh$3.8M+824.1%
Bank of New York Mellon#50 · 250,783 sh$3.6M-1.8%
MYDA Advisors#51 · 250,000 sh$3.6M-24.2%
UBS Group AG#52 · 241,363 sh$3.5M+86.4%
BNP Paribas Asset Management Holding S.A.#53 · 234,809 sh$3.4M-4.3%
Schonfeld Strategic Advisors#54 · 229,780 sh$3.3M+10.9%
WELLINGTON MANAGEMENT GROUP LLP#55 · 228,559 sh$3.3M-11.7%
Nuveen#56 · 193,480 sh$2.8M-25.7%
Propel Bio Management#57 · 191,745 sh$2.7M-11.2%
Qube Research & Technologies Ltd#58 · 189,102 sh$2.7M+62.4%
Walleye Capital#59 · 188,221 sh$2.7M-37.3%
Susquehanna Portfolio Strategies#60 · 187,801 sh$2.7M+34.7%
SCHRODER INVESTMENT MANAGEMENT GROUP#61 · 169,334 sh$2.4M-22.5%
HighVista Strategies#62 · 155,704 sh$2.2M-14.9%
DEUTSCHE BANK AG\#63 · 152,799 sh$2.2M-36.1%
Granahan Investment Management#64 · 149,387 sh$2.1M-49.7%
Swiss National Bank#65 · 142,300 sh$2.0M-3.5%
STATE OF WISCONSIN INVESTMENT BOARD#66 · 139,770 sh$2.0M+10.3%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME#67 · 135,340 sh$1.9M-9.7%
PANAGORA ASSET MANAGEMENT#68 · 132,214 sh$1.9M0.0%
Corient Private Wealth#69 · 127,199 sh$1.8M-0.2%
PRICE T ROWE ASSOCIATES#70 · 124,989 sh$1.8M+17.8%
ESSEX INVESTMENT MANAGEMENT#71 · 121,684 sh$1.7M-4.3%
Invesco Ltd.#72 · 116,204 sh$1.7M-11.9%
Russell Investments Group, Ltd.#73 · 110,069 sh$1.6M+53.7%
Squarepoint Ops#74 · 98,002 sh$1.4M+22.3%
RHUMBLINE ADVISERS#75 · 97,437 sh$1.4M+0.8%
SG Americas Securities#76 · 88,802 sh$1.3MNew
ALGERT GLOBAL#77 · 78,990 sh$1.1MNew
Waverly Advisors#78 · 77,914 sh$1.1M0.0%
Cinctive Capital Management#79 · 72,582 sh$1.0M+160.5%
WELLS FARGO & COMPANY#80 · 70,739 sh$1.0M+141.5%
WOODSTOCK#81 · 68,465 sh$979.0K0.0%
ALLIANCEBERNSTEIN L.P.#82 · 75,336 sh$971.1K0.0%
BANK OF AMERICA#83 · 65,048 sh$930.2K-83.0%
JANE STREET GROUP#84 · 62,939 sh$900.0K+70.4%
Zurcher Kantonalbank (Zurich Cantonalbank)#85 · 60,539 sh$865.7K+179.7%
Legal & General Group Plc#86 · 59,220 sh$846.8K+11.5%
FOX RUN MANAGEMENT, L.L.C.#87 · 58,528 sh$837.0KNew
HRT FINANCIAL#88 · 57,212 sh$818.0K+43.0%
Y-Intercept (Hong Kong) Ltd#89 · 51,190 sh$732.0KNew
VOYA INVESTMENT MANAGEMENT#90 · 50,089 sh$716.3K+4.9%
SILVERBACK ASSET MANAGEMENT#91 · 50,000 sh$715.0K0.0%
JPMORGAN CHASE#92 · 50,053 sh$706.2K+24.8%
Erste Asset Management GmbH#93 · 50,000 sh$705.5K0.0%
VANGUARD ASSET MANAGEMENT, Ltd#94 · 49,129 sh$702.5K0.0%
Point72 Asset Management, L.P.#95 · 48,574 sh$694.6KNew
SBI Okasan Asset Management Ltd.#96 · 45,700 sh$644.8K0.0%
BARCLAYS PLC#97 · 43,948 sh$628.5K+68.0%
MetLife Investment Management#98 · 43,469 sh$621.6K0.0%
SCOTIA CAPITAL#99 · 41,751 sh$597.0K0.0%
Marex Group plc#100 · 41,300 sh$590.6K-26.7%

Funds that sold out of EYPT in Q2 2026 (23)

Held EYPT at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.

Institutions that held EYPT in Q1 2026 and reported no position in Q2 2026.
InstitutionValue in Q1 2026
ExodusPoint Capital Management458,102 sh$5.9M
DIADEMA PARTNERS178,545 sh$2.3M
RENAISSANCE TECHNOLOGIES117,300 sh$1.5M
XTX Topco Ltd66,646 sh$859.1K
Persistent Asset Partners Ltd58,995 sh$760.4K
TWINBEECH CAPITAL56,300 sh$725.7K
AQR CAPITAL MANAGEMENT17,712 sh$228.3K
RWC Asset Management LLP17,652 sh$227.5K
LANDSCAPE CAPITAL MANAGEMENT, L.L.C.12,283 sh$158.3K
Dynamic Technology Lab Private Ltd12,067 sh$155.5K
Vanguard Personalized Indexing Management11,122 sh$143.4K
Scientech Research10,405 sh$134.1K
AMERICAN CENTURY COMPANIES10,185 sh$131.3K
Winthrop Advisory Group10,100 sh$130.2K
Aquatic Capital Management6,387 sh$82.3K
QUADRANT CAPITAL GROUP200 sh$50.3K
Centiva Capital216 sh$2.8K
HUNTINGTON NATIONAL BANK144 sh$1.9K
Advisory Services Network76 sh$980.00
MAI Capital Management15 sh$194.00
Root Financial Partners5 sh$64.00
TWIN PEAKS WEALTH ADVISORS1 sh$13.00
Hughes Financial Services1 sh$13.00

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.